Cefuroxime, sold under the brand name Zinacef among others, is a second-generation cephalosporin antibiotic used to treat and prevent a number of bacterial infections. These include pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease. It is used by mouth or by injection into a vein or muscle.
via PubMed
{{Drugbox | Watchedfields = changed | verifiedrevid = 460025245 | IUPAC_name = (6R,7R)-3-{[(Aminocarbonyl)oxy]methyl}-7-{[(2Z)-2-(2-furyl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | image = Cefuroxime enantiomers skeletal formula labelled.svg | width = 400 | image_class = skin-invert-image | alt = Skeletal formula of cefuroxime | image2 = Cefuroxime_enantiomers_ball-and-stick_models_from_xtal_2000.png | image_class2 = bg-transparent | width2 = 400 | alt2 = Ball-and-stick models of cefuroxime based on X-ray crystallography data.
| tradename = Zinacef, others | Drugs.com = | MedlinePlus = a601206 | DailyMedID = Cefuroxime | pregnancy_category = | routes_of_administration = Intramuscular, intravenous, by mouth | class = Second-generation cephalosporin | ATC_prefix = J01 | ATC_suffix = DC02 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).